Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Pharmaceuticals
3 Great Stock Market Sectors Millennials Should Invest In
Investing in stocks can be tricky for newcomers, but these three sectors can give millennials a good place to start.
Drug Pricing Turns to Insulin as Politicians, AMA and Docs Look to Pharma
Insulin has been around since 1921. But there is no generic drug and four companies control the market. Now politicians, the AMA and patient groups are looking for lower prices.
Novo Nordisk Stock Rises 4% Over 2 Sessions
Pharma firm's new diabetes drug showed positive test results.
Sprout CEO: Don't Call Her Drug the Female Viagra
Sprout Pharmaceuticals CEO Cindy Eckert is a crusader -- for women with low sex drive and for female biotech start-ups. And this crusader only wears pink. Watch!
Novo Nordisk Stock Pops Nearly 3% on Positive Diabetes-Drug Results
The Danish company's shares are enjoying their best day since May 2.
Mesoblast Soars on Stem-Cell Treatment Data
The Australian company unveiled data from a study evaluating a potential treatment for children with steroid refractory acute Graft Versus Host Disease.
Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus
After Purdue let some of its sales staff go in February, it followed up June 20 by sending the rest of the staff packing.
Sarepta Shares Keep Climbing and PTC Therapeutics Bounces Back
Sarepta adds another 7% on top of nearly 40% gains on Tuesday following good results for a new gene therapy.
Biotech Firm Sarepta Surges 40% on Positive Test Results
But rival firm PTC Therapeutics tumbles nearly 31% on the news.
Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy
The Duchenne Muscular Dystrophy specialist announces early results that show a gene-based treatment for the debilitating disease may be just two years away.